Over 9,000 deaths due to respiratory diseases in Delhi
New Delhi: The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according…
Ayurveda practitioner fined by ISM Council for violation of professional ethics
Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…
Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts
Hyderabad: While most people know that a dog bite requires immediate medical attention, a critical detail that is often overlooked is where exactly should the injection be administered? People should…
DoP calls for proposals to set up common facilities for medical device clusters
New Delhi: The Department of Pharmaceuticals (DoP) has invited applications from eligible stakeholders to set up common facilities for medical device clusters in the country, under the scheme for Strengthening…
Quality of generic drugs as good as that of costlier branded cousins: Study
NEW DELHI: A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded drugs and the far cheaper generics, including govtsupplied medicines, even as…
Piyush Goyal meets pharma stakeholders to discuss growth, regulation amid global tariff concerns
Union Minister of Commerce and Industry, Piyush Goyal, held an interaction with key stakeholders from India’s pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms. In a social media…
Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Hyderabad: In a ray of hope for HIV patients, particularly for the significant burden in the two-Telugu speaking States of Telangana and Andhra Pradesh, several India pharmaceutical companies have secured…
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves…
US Tariffs on pharma: What are the potential impact on Indian drugmakers
US tariffs on pharmaceutical imports by the US President Donald Trump have sparked concerns within India’s pharma sector, a global leader in affordable generic drug supplies. In an exclusive interaction…
